Rhus Toxicodendron 30 [hp_C]/1
TOXICODENDRON PUBESCENS LEAF · PELLET · SEVENE USA
Rhus Toxicodendron is a pellet containing toxicodendron pubescens leaf at 30 [hp_C]/1, taken sublingual. Manufactured by SEVENE USA.
Key Facts
- Brand Name
- Rhus Toxicodendron
- Generic Name
- TOXICODENDRON PUBESCENS LEAF
- NDC Code (Product)
76472-1159- Manufacturer
- SEVENE USA
- Strength
- 30 [hp_C]/1
- Dosage Form
- PELLET
- Route
- SUBLINGUAL
- Marketing Status
- Marketing Start
- 11/30/2011
Recall History
Washington Homeopathic Products, Inc.
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Washington Homeopathic Products, Inc.
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Washington Homeopathic Products, Inc.
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Frequently Asked Questions
What is Rhus Toxicodendron used for?
Rhus Toxicodendron contains TOXICODENDRON PUBESCENS LEAF. It is a pellet taken sublingual. Consult your doctor for specific uses.
Is Rhus Toxicodendron a controlled substance?
Rhus Toxicodendron is not classified as a controlled substance by the DEA.
What is the generic name for Rhus Toxicodendron?
The generic name for Rhus Toxicodendron is TOXICODENDRON PUBESCENS LEAF. There are 11 other brand versions of TOXICODENDRON PUBESCENS LEAF.
What is the NDC code for Rhus Toxicodendron 30 [hp_C]/1?
The NDC (National Drug Code) for Rhus Toxicodendron 30 [hp_C]/1 is 76472-1159, listed by SEVENE USA.
Other Toxicodendron Brands
See all →- Rhus tox1 [hp_M]/[hp_M]0220-4386
- Rhus tox12 [hp_C]/12[hp_C]0220-4398
- TOXICODENDRON PUBESCENS LEAF4 [hp_X]/30mL53499-2991
- Rhus tox15 [hp_C]/15[hp_C]0220-4399
- WHP Poison Ivy4 [hp_X]/171919-823
- Rhus toxicodendron7 [hp_X]/10220-4393
- Rhus tox6 [hp_C]/6[hp_C]0220-4396
- Rhus tox30 [hp_C]/30[hp_C]0220-4400
- Rhus tox30 [hp_X]/30[hp_X]0220-4417
- Rhus tox10 [hp_M]/10[hp_M]0220-4387
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)